Performance Analysis of Biohealthcare and Semiconductor Stock ETFs
Samsung Active Asset Management's 'KoAct BioHealthcare Active' has become the largest bio-healthcare ETF in South Korea by net asset size. Since its listing in August, the ETF has shown consistent growth, now boasting net assets of 230.3 billion won. The primary portfolio includes stocks like ABL Bio and Alteogen, effectively adapting to market changes to achieve high returns. Recent figures show a three-month performance of 18.6% and a year-to-date return of 34.5%. This success can be attributed to a strategic investment in AI-aided bio-healthcare companies, tailored to an aging society.
The 'CSOP Samsung Electronics Daily 2X Leverage' ETF has more than doubled in price just about four months post-listing, supported by the rising share prices of Samsung Electronics. The anticipated improvement in profitability of Samsung's key semiconductor products and continued foreign investor purchases have positively impacted the ETF's performance. It aims to track twice the rate of increase in Samsung Electronics' stock price, nearing a rise of 110% post-listing. Nonetheless, investors should be mindful of the significant volatility risk inherent in leveraged ETFs.
Related ETF
Related News
Samsung Active's Bio Healthcare ETF, Net Assets No. 1 Among Domestic Similar Types - Seoul Economic DailySecurities > Domestic Stock Market News: Samsung Active Asset Management's 'KoAct Bio Healthcare Active', the nation's first bio active exchange-traded fund (ETF), leads the domestic bio and healthcare ...
Related ETF
KoAct Bio Healthcare Active ranks No.1 in net assets among domestic Bio·Healthcare ETFs - EdailySamsung Active Asset Management announced on the 19th that 'KoAct Bio Healthcare Active,' the first bio-active exchange-traded fund (ETF) in Korea, has ranked No.1 in net asset size among domestic Bio·Healthcare ETFs. (Photo=Samsung Active Asset Management) KoAct Bio Healthcare Active was introduced in August 2023 ...
Related ETF
조선일보2025 9月 18
Samsung Electronics Leverage ETF Doubles in 4 Months Since Listing - Chosun IlboThe Samsung Electronics Leverage ETF has more than doubled in value in just 4 months since its listing as semiconductor prices rose, improving profitability. It's important to be cautious of volatility in leverage products. As Samsung Electronics' stock price recovers to 80,000 KRW, the price of the leveraged exchange-traded fund (ETF), which uses only Samsung Electronics stock as the underlying asset, also more than doubled in about four months since its listing.